For the last 50 years, healthcare has focused on symptoms of heart disease rather than the disease itself, atherosclerosis. The Cleerly team has spent more than a decade performing some of the largest clinical trials to identify the most important indicators beyond symptoms that increase a person’s risk of heart attacks.
Cleerly technology goes beyond traditional measures of heart disease by enabling comprehensive quantification and characterization of plaque buildup, in each of the heart arteries. Our analysis supports your physician in determining your risk of heart attack and guiding your treatment plan to maintain heart health. Learn more at our website!